Pasar al contenido principal

VALOR PRONOSTICO DE LA HEMOLISIS INTRAVASCULAR EN PACIENTES CON ESTENOSIS AORTICA SEVERA TRATADOS CON IMPLANTE PERCUTANEO DE LA VALVULA AÓRTICA.

PI21/00949

•
Nombre agencia financiadora Instituto de Salud Carlos III
Acrónimo agencia financiadora ISCIII
Programa Programa Estatal de Generación de Conocimiento y Fortalecimiento del Sistema Español de I+D+I
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de Investigación en Salud
Año convocatoria 2021
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario FUNDACION INVESTIGACION BIOMEDICA DE CORDOBA (FIBICO)
Centro realización INSTITUTO MAIMONIDES DE INVESTIGACION BIOMEDICA DE CORDOBA (IMIBIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Stroke-associated pneumonia according to mCDC criteria, impact on prognosis and antibiotic therapy

  • Rabaneda-Lombarte, Neus
  • Faura, Júlia|||0000-0002-8436-1377
  • Ezcurra Diaz, Garbiñe|||0000-0002-9511-3117
  • Olivé-Gadea, Marta|||0000-0003-4637-1598
  • Álvarez-Larruy, Marta|||0000-0003-0119-5607
  • Vidal-de Francisco, Diana
  • Domínguez-Mayoral, Ana
  • Avellaneda-Gómez, Carla|||0000-0003-4851-1224
  • Freijo, Mari Mar
  • Zapata-Arriaza, Elena|||0000-0002-1730-1999
  • Serrano-Heras, Gemma|||0000-0001-9368-4832
  • Alcahut-Rodríguez, Cristian
  • Fernandez-Perez, Isabel|||0000-0002-9949-1393
  • Moniche, Francisco|||0000-0001-8613-2909
  • Pérez-Sánchez, Soledad|||0000-0002-8940-9763
  • Millán Torné, Mònica|||0000-0002-4692-5936
  • Rubiera, Marta
  • Dorado Bouix, Laura|||0000-0003-1095-6797
  • Maisterra Santos, Olga
  • Montaner, Joan|||0000-0003-4845-2279
  • Bustamante, Alejandro|||0000-0003-4390-8900
Objective: The modified Centers for Disease Control and Prevention (mCDC) criteria have been proposed for diagnosing and managing stroke-associated pneumonia (SAP). The objective was to investigate the impact of SAP on stroke outcome depending on whether or not it conforms to mCDC criteria. Our secondary objective was to identify the responsible factors for antibiotic initiation in stroke patients. Methods: We conducted a prospective, multicenter, observational study of ischemic stroke patients with moderate to severe stroke (NIHSS≥4) admitted within 24 h. For 7 days, mCDC criteria were assessed daily, and infections and antibiotics were recorded. Pneumonias were divided into those fulfilling mCDC criteria (mCDC-SAP) or not (other pneumonias, OPn). The effect of each type of pneumonia on 3-month outcome was evaluated in separated logistic regression models. Factors associated with antibiotic initiation were explored using a random forest analysis. Results: Of the 342 patients studied, infections were diagnosed in 72 (21.6%), including 39 (11.7%) cases of pneumonia. Of them, 25 (7.5%) fulfilled mCDC criteria. Antibiotics were used in 92% of mCDC-SAP and 64.3% of OPn. In logistic regression analysis, mCDC-SAP, but not OPn, was an independent predictor of poor outcome [OR, 4.939 (1.022-23.868)]. The random forest analysis revealed that fever had the highest importance for antibiotic initiation. Interpretation: The mCDC criteria might be useful for detecting clinically relevant SAP, which is associated with poor outcomes. Isolated signs of infection were more important for antibiotic initiation than compliance with pre-defined criteria. Therefore, adherence to mCDC criteria might result in antibiotic saving without compromising clinical outcome.